New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
Abstract The dopamine D2 receptor (D2R) is the target of drugs used to treat the symptoms of Parkinson’s disease and schizophrenia. The D2R is regulated through its interaction with and phosphorylation by G protein receptor kinases (GRKs) and interaction with arrestins. More recently, D2R arrestin-m...
Guardado en:
Autores principales: | Anika Mann, Alastair C. Keen, Hanka Mark, Pooja Dasgupta, Jonathan A. Javitch, Meritxell Canals, Stefan Schulz, J. Robert Lane |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca749480bcc9489bb045eb4ed1f42bf3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies
por: Anika Mann, et al.
Publicado: (2020) -
14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites
por: Matej Horvath, et al.
Publicado: (2021) -
Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
por: Kumiko Taguchi, et al.
Publicado: (2017) -
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
por: David A. Sykes, et al.
Publicado: (2017) -
Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’
por: David A. Sykes, et al.
Publicado: (2018)